Gina Alejandra Castiblanco Rubio

Dr. Gina Alejandra Castiblanco Rubio

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2016 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
GRGina Alejandra Castiblanco Rubio
Gina Alejandra Castiblanco Rubio
TYTülay Tülay Yucel-Lindberg
Tülay Tülay Yucel-Lindberg
SRStefan Roos
Stefan Roos
STSvante Twetman
Svante Twetman

2 April 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
GRGina Alejandra Castiblanco Rubio
Gina Alejandra Castiblanco Rubio
E Angeles Martinez-MierE Angeles Martinez-Mier
E Angeles Martinez-Mier
Epidemiological studies use biomarkers of fluoride exposure in pregnant women as surrogate measures of fetal fluoride exposure; however, there is little understanding of how pregnancy affects fluoride metabolism and its biomarkers. This narrative review summarizes the changes of pregnancy that have the potential to impact fluoride’s absorption, distribution and excretion, and highlights the limited body of evidence on the topic. The physiologic systems that experience pregnancy-associated changes relevant to fluoride’s metabolism are the cardiovascular, renal, metabolic and gastrointestinal, as well bone and calcium metabolism and the body’s acid-base balance. The available evidence indicates that fluoride is found in the maternal plasma and urine, placenta, amniotic fluid and fetus. Although plasma and urinary fluoride vary across gestation, there is insufficient quality evidence to determine the direction or extent of such variation. Furthermore, there is no doubt that fluoride from maternal blood crosses the placenta and is absorbed and excreted by the fetus; however, the biological mechanisms behind this placental passage are unknown. Research on maternal and prenatal biomarkers of fluoride exposure would benefit from studies on how pregnancy-associated changes affect the metabolism of fluoride across gestation, the mechanisms for the intestinal absorption of fluoride in pregnant women, and the placental passage of fluoride.

26 June 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
GRGina Alejandra Castiblanco Rubio
Gina Alejandra Castiblanco Rubio
TRTeresa Verenice Muñoz Rocha
Teresa Verenice Muñoz Rocha
Martha María Téllez-RojoMartha María Téllez-Rojo
Martha María Téllez-Rojo
AEAdrienne S. Ettinger
Adrienne S. Ettinger
AMAdriana Mercado-García
Adriana Mercado-García
E Angeles Martinez-MierE Angeles Martinez-Mier
E Angeles Martinez-Mier

10 October 2025 in Metabolomics
Verified
Journal Article
Open access
PDF file
Guillermo Tamayo-CabezaGuillermo Tamayo-Cabeza
Guillermo Tamayo-Cabeza
GRGina Alejandra Castiblanco Rubio
Gina Alejandra Castiblanco Rubio
E Angeles Martinez-MierE Angeles Martinez-Mier
E Angeles Martinez-Mier
Background: Evidence from in-vitro and animal studies suggests that fluoride exposure may alter key metabolic pathways such as amino acid, fatty acid and energy metabolism in different tissues, requiring an understanding of its impact at the molecular level, especially in human populations. Aim of review: This scoping review aims to systematically map and synthesize the available evidence on metabolic alterations associated with fluoride exposure, specifically focusing on studies employing metabolomic analysis techniques to identify altered metabolites and metabolic pathways at the cellular, tissue, and organ levels. Key scientific concepts of review: Fluoride exposure has been found to alter a broad range of metabolic pathways, including those involved in energy metabolism (glycolysis, TCA cycle, mitochondrial activity), macromolecule metabolism (purine and fatty acid metabolism, amino acid pathways), and cellular stress responses (oxidative stress and glutathione metabolism). However, there is limited evidence in humans and potential mechanistic studies. While supportive, the reliance on animal models and in-vitro studies points to the need for human studies to compare metabolic alterations at different levels of fluoride exposure to aid in understanding the systemic effects of fluoride on human health.

16 February 2017 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
GRGina Alejandra Castiblanco Rubio
Gina Alejandra Castiblanco Rubio
TYTulay Yucel-Lindberg
Tulay Yucel-Lindberg
SRStefan Roos
Stefan Roos
STSvante Twetman
Svante Twetman

19 February 2021 in Public Health Nutrition
Verified
Journal Article
Closed access
PDF file
GRGina Alejandra Castiblanco Rubio
Gina Alejandra Castiblanco Rubio
TRTeresa Verenice Muñoz Rocha
Teresa Verenice Muñoz Rocha
ACAlejandra Cantoral
Alejandra Cantoral
MTMartha M. Téllez-Rojo
Martha M. Téllez-Rojo
AEAdrienne S. Ettinger
Adrienne S. Ettinger
EMEsperanza A Martínez-Mier
Esperanza A Martínez-Mier
Objective: To estimate dietary fluoride intake (F-) over the course of pregnancy and the overall adjusted difference in dietary F- intake by pregnancy stages and levels of compliance with dietary recommendations. Design: Secondary data analysis from a longitudinal pregnancy cohort study in a population exposed to fluoridated salt. Women were followed during the early, middle and late stages of their pregnancy (n=568). The dietary intake of recommended prenatal nutrients according to Mexican dietary guidelines and F- intake (mg/day) were estimated with a validated Food Frequency Questionnaire. Data were summarized with descriptive statistics. Levels of F- intake were compared to the USA’s IOM Adequate Intake (AI) of 3 mg/day for pregnancy. Adjusted differences in F- intake by pregnancy stages and levels of compliance with recommendations were estimated using random effects models. Setting: Mexico City. Participants: Women participating in the Early Life Exposures in Mexico to ENvironmental Toxicants (ELEMENT) project, from 2001 to 2003. Results: Median dietary F- intake (IQR) throughout pregnancy ranged from 0.64 (0.38) in the early-, to 0.70 (0.42) in the middle-, and 0.72 (0.44) mg/day in the late-stage (0.01 mg F-/kg/day). Corresponding adjusted intakes of F- [95% CI] were 0.72 [0.70-0.74], 0.76 [0.74-0.77], and 0.80 [0.78-0.82] mg/day. Women who were moderately and highly compliant with Mexican dietary recommendations ingested, on average, 0.04 and 0.14 mg F-/day more than non-compliant women (p<0.005). Conclusions: Dietary F- intake was below current AI, was greater with the progression of pregnancy and in women who were moderately and highly compliant with dietary recommendations.